Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity

par Counts, Scott E., Mufson, Elliott J.
Publié 2010

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

par Counts, Scott E., Mufson, Elliott J.
Publié 2010

Multi-Infarct Dementia: A Historical Perspective

par McKay, Erin, Counts, Scott E.
Publié dans Dement Geriatr Cogn Dis Extra (2017)

Regulator of Cell Cycle (RGCC) Expression during the Progression of Alzheimer's Disease

par Counts, Scott E., Mufson, Elliott J.
Publié dans Cell Transplant (2017)

Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD

par Counts, Scott E., Lahiri, Debomoy K.
Publié dans Curr Alzheimer Res (2014)

Oxytocin Receptor Signaling in Vascular Function and Stroke

par McKay, Erin C., Counts, Scott E.
Publié dans Front Neurosci (2020)

Vascular cognitive impairment and dementia

par Gorelick, Philip B., Counts, Scott E., Nyenhuis, David
Publié dans Biochim Biophys Acta (2015)

Evidence for Mitochondrial UPR Gene Activation in Familial and Sporadic Alzheimer’s Disease

par Beck, John S., Mufson, Elliott J., Counts, Scott E.
Publié dans Curr Alzheimer Res (2016)

Pontine Arteriolosclerosis and Locus Coeruleus Oxidative Stress Differentiate Resilience from Mild Cognitive Impairment in a Clinical Pathologic Cohort

par Kelly, Sarah C, Nelson, Peter T, Counts, Scott E
Publié dans J Neuropathol Exp Neurol (2021)

Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment

par Weinberg, Rebecca B., Mufson, Elliott J., Counts, Scott E.
Publié dans Front Neurosci (2015)

Preservation of cortical sortilin protein levels in MCI and Alzheimer’s disease

par Mufson, Elliott J., Wuu, Joanne, Counts, Scott E., Nykjaer, Anders
Publié 2010

Gender differences in NGF receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer’s disease

par Counts, Scott E., Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publié 2011

Single cell gene expression profiling in Alzheimer’s disease

par Ginsberg, Stephen D., Che, Shaoli, Counts, Scott E., Mufson, Elliott J.
Publié 2012

Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease

par Tiernan, Chelsea T, Mufson, Elliott J, Kanaan, Nicholas M, Counts, Scott E
Publié dans J Neuropathol Exp Neurol (2018)

Intravenous Immunoglobulin Reduces Tau Pathology and Preserves Neuroplastic Gene Expression in the 3xTg Mouse Model of Alzheimer’s Disease

par Counts, Scott E., Perez, Sylvia E., He, Bin, Mufson, Elliott J.
Publié dans Curr Alzheimer Res (2014)

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

par Mufson, Elliott J, Counts, Scott E, Perez, Sylvia E, Ginsberg, Stephen D
Publié 2008

Neuroprotective Role for Galanin in Alzheimer’s Disease

par Counts, Scott E., Perez, Sylvia E., Ginsberg, Stephen D., Mufson, Elliott J.
Publié 2010

Galanin Hyperinnervation Upregulates Choline Acetyltransferase Expression in Cholinergic Basal Forebrain Neurons in Alzheimer's Disease

par Counts, Scott E., He, Bin, Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publié 2008

Galanin Fiber Hyperinnervation Preserves Neuroprotective Gene Expression in Cholinergic Basal Forebrain Neurons in Alzheimer’s Disease

par Counts, Scott E., He, Bin, Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publié 2009

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

par Fonseca, Maria I, McGuire, Susan O, Counts, Scott E, Tenner, Andrea J
Publié 2013